Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Microbial Limit Testing – V 2.0

Posted on By

Elixir Department: SOP for Microbial Limit Testing – V 2.0

Standard Operating Procedure for Microbial Limit Testing of Elixir Formulations

Department Elixir Department
SOP No. SOP/ELX/217/2025
Supersedes SOP/ELX/217/2022
Page No. Page 1 of 9
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To describe the procedure for determining the microbial limits in elixir formulations in accordance with pharmacopeial guidelines to ensure the product is free from harmful microbial contamination and suitable for consumption.

2. Scope

This SOP is applicable to Quality Control personnel responsible for testing finished elixir batches for Total Aerobic Microbial Count (TAMC), Total Yeast and Mold Count (TYMC), and specified microbial organisms.

3. Responsibilities

  • QC Microbiologist:
    • Prepare media, perform microbial testing, and record observations.
  • QC Supervisor:
    • Verify test conditions and ensure aseptic sampling practices are followed.
  • QA Officer:
    • Review and approve test results and initiate corrective action for OOS findings.

See also  Elixir Department: SOP for Viscosity Comparison Between Batches - V 2.0

4. Accountability

The QC Head is accountable for ensuring proper microbial limit testing and documentation. QA Head is responsible for ensuring all results meet regulatory and internal standards.

5. Procedure

5.1 Sample Handling

type="1">
  • Collect a representative sample of the final product using sterile techniques.
  • Label containers properly with batch number, product name, and date of sampling.
  • Perform testing within 24 hours of sampling or store at 2–8°C until testing.
  • 5.2 Media and Reagents

    1. Use media prepared as per pharmacopeial guidelines:
      • Plate Count Agar for TAMC
      • Sabouraud Dextrose Agar for TYMC
      • Selective media for E. coli, Salmonella, S. aureus, P. aeruginosa
    2. Sterilize all media and equipment using validated autoclave cycles.

    5.3 Sample Preparation

    1. Prepare a 1:10 dilution of the elixir sample using sterile 0.1% peptone water or buffer solution.
    2. If product contains preservatives, perform neutralization using validated neutralizing agents.

    See also  Elixir Department: SOP for Automated Transfer System Controls - V 2.0

    5.4 Plate Inoculation

    1. Inoculate 1 mL of diluted sample onto duplicate plates of Plate Count Agar and Sabouraud Dextrose Agar.
    2. Spread uniformly using a sterile spreader.
    3. For specified pathogens, inoculate 10 mL of sample into enrichment broth followed by plating onto selective media.

    5.5 Incubation Conditions

    • TAMC: 30–35°C for 48–72 hours
    • TYMC: 20–25°C for 5–7 days
    • Specified Microorganisms: As per individual test method (usually 24–48 hours)

    5.6 Interpretation of Results

    1. Count colony forming units (CFU) and calculate per mL of sample.
    2. Acceptance Criteria (as per USP/Ph. Eur. for oral preparations):
      • TAMC: NMT 103 CFU/mL
      • TYMC: NMT 102 CFU/mL
      • Specified Pathogens: Absent in 1 mL

    5.7 Documentation

    1. Enter all results in the Microbial Limit Test Logbook (Annexure-1).
    2. Attach raw data sheets, incubation records, and CFU count photos to the BMR.

    6. Abbreviations

    • TAMC: Total Aerobic Microbial Count
    • TYMC: Total Yeast and Mold Count
    • CFU: Colony Forming Units
    • SOP: Standard Operating Procedure
    • QC: Quality Control
    • QA: Quality Assurance
    See also  Elixir Department: SOP for Use of Mixing Tanks with Variable Speed Agitators - V 2.0

    7. Documents

    1. Microbial Limit Test Logbook (Annexure-1)
    2. Incubation Records
    3. Batch Manufacturing Record (BMR)

    8. References

    • USP <61> – Microbial Enumeration Tests
    • USP <62> – Tests for Specified Microorganisms
    • 21 CFR Part 211.165 – Testing and Release for Distribution

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Microbial Limit Test Logbook

    Date Batch No. TAMC (CFU/mL) TYMC (CFU/mL) Specified Organisms Tested By Verified By
    11/04/2025 ELX-0425-035 220 20 Absent Rajesh Kumar Sunita Reddy

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Release New SOP QA Head
    11/04/2025 2.0 Included neutralization and TYMC method update Regulatory Update QA Head
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Analytical Method Development: SOP for Qualification of Receiving Laboratory – V 2.0
    Next Post: How to Create an SOP for Temperature Excursions During Pharma Transport

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version